The value of new biomarkers or imaging tests, when added to a prediction model, is currently evaluated using reclassification measures, such as the net reclassification improvement (NRI). However, these measures only provide an estimate of improved reclassification at population level. We present a straightforward approach to characterize subgroups of reclassified individuals in order to tailor implementation of a new prediction model to individuals expected to benefit from it.In a large Dutch population cohort (n = 21,992) we classified individuals to low (<5%) and high (≥5%) fatal cardiovascular disease risk by the Framingham risk score (FRS) and reclassified them based on the systematic coronary risk evaluation (SCORE). Subsequently, we ...
Reclassification is observed even when there is no or minimal improvement in the area under the rece...
More and more biomarkers are becoming available to predict the risk of disease. Several performance ...
textabstractBackground: Whether newer risk markers for coronary heart disease (CHD) improve CHD risk...
Background The value of new biomarkers or imaging tests, when added to a prediction model, is curren...
Background The value of new biomarkers or imaging tests, when added to a prediction model, is curren...
Appropriate quantification of added usefulness offered by new markers included in risk prediction al...
Models for risk prediction are widely used in clinical practice to stratify risk and assign treatmen...
<p>This figure shows that at level 1, assessing the incremental performance, a new prediction model ...
Background Case-cohort studies are increasingly used to quantify the association of novel factors w...
markdownabstractIntroduction For the last three decades, clinical prediction models have mainly b...
New markers may improve prediction of diagnostic and prognostic outcomes. We aimed to review options...
New markers may improve prediction of diagnostic and prognostic outcomes. We aimed to review options...
New markers may improve prediction of diagnostic and prognostic outcomes. We aimed to review options...
Reclassification is observed even when there is no or minimal improvement in the area under the rece...
ObjectivesThe purpose of this study was to determine net reclassification improvement (NRI) and impr...
Reclassification is observed even when there is no or minimal improvement in the area under the rece...
More and more biomarkers are becoming available to predict the risk of disease. Several performance ...
textabstractBackground: Whether newer risk markers for coronary heart disease (CHD) improve CHD risk...
Background The value of new biomarkers or imaging tests, when added to a prediction model, is curren...
Background The value of new biomarkers or imaging tests, when added to a prediction model, is curren...
Appropriate quantification of added usefulness offered by new markers included in risk prediction al...
Models for risk prediction are widely used in clinical practice to stratify risk and assign treatmen...
<p>This figure shows that at level 1, assessing the incremental performance, a new prediction model ...
Background Case-cohort studies are increasingly used to quantify the association of novel factors w...
markdownabstractIntroduction For the last three decades, clinical prediction models have mainly b...
New markers may improve prediction of diagnostic and prognostic outcomes. We aimed to review options...
New markers may improve prediction of diagnostic and prognostic outcomes. We aimed to review options...
New markers may improve prediction of diagnostic and prognostic outcomes. We aimed to review options...
Reclassification is observed even when there is no or minimal improvement in the area under the rece...
ObjectivesThe purpose of this study was to determine net reclassification improvement (NRI) and impr...
Reclassification is observed even when there is no or minimal improvement in the area under the rece...
More and more biomarkers are becoming available to predict the risk of disease. Several performance ...
textabstractBackground: Whether newer risk markers for coronary heart disease (CHD) improve CHD risk...